Dr. Salit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-667-1317Fax+1 410-328-0267- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2007 - 2011
University of MarylandResidency, Internal Medicine, 2004 - 2007
Loyola University Chicago Stritch School of MedicineClass of 2004
Certifications & Licensure
WA State Medical License 2012 - 2025
MD State Medical License 2007 - 2013- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders Start of enrollment: 2009 Aug 25
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Start of enrollment: 2010 May 19
- Join now to see all
Publications & Presentations
PubMed
- Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective.Xinyi Fan, Ailie Armstrong, Masumi Ueda Oshima, Karen L Syrjala, Rachel B Salit, Stephanie J Lee, Neel S Bhatt, Paul A Carpenter, Laura Connelly-Smith, Elizabeth Krako...> ;Transplantation and Cellular Therapy. 2024 Mar 30
- Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.Marivel Ortega, Constance Missimer, Masumi Ueda Oshima, Rahul Banerjee, Andrew J Cowan, Paul A Carpenter, Rachel B Salit, Phuong T Vo, Catherine J Lee, Rohtesh S Mehta...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 23
- 1 citationsIndication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group.Kröger, N., Bacigalupo, A., Barbui, T., Ditschkowski, M., Gagelmann, N., Griesshammer, M., Gupta, V., Hamad, N., Harrison, C., Hernandez-Boluda, J., Koschmieder, S., J...> ;The Lancet. Haematology. 2024 Jan 1
- Join now to see all
Journal Articles
- Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell TransplantationMary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica
Abstracts/Posters
- Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative SyndromesRachel B. Salit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral ProphylaxisRachel B. Salit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant: A Report from the Center for International Blood and Marrow Transplan...Rachel B. Salit, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Fred Hutchinson Cancer CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
